Clinical Response to Biomarker Documentation of Child Secondhand Smoke Exposure
1 other identifier
interventional
80
1 country
1
Brief Summary
- 1.To do formative work with healthcare providers, clinic staff and parents to develop a protocol for a clinic system to routinely collect blood from children at risk of SHS exposure conduct laboratory testing for tobacco toxicants, document exposure in the electronic medical record (EMR) and incorporate the biomarker feedback into a parental smoking treatment plan.
- 2.To pilot test effects of a clinic system to screen children at risk of SHS exposure with laboratory testing for tobacco toxicants on provider delivery of tobacco treatment services (primary outcome).
- 3.To pilot test effects of a clinic system to screen children at risk of SHS exposure with laboratory testing for tobacco toxicants on parent smoking behavior (participation in smoking cessation treatment, smoking cessation and implementation of smoking restrictions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2010
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
June 16, 2010
CompletedFirst Posted
Study publicly available on registry
June 17, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJune 17, 2010
March 1, 2010
6 months
June 16, 2010
June 16, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Provider Delivery of Tobacco Treatment Services
Whether or not biomarker feedback testing of secondhand smoke will prompt providers to deliver tobacco treatment services
12 weeks
Secondary Outcomes (1)
Parent Smoking Behavior
12 weeks
Study Arms (2)
Biomarker feedback
ACTIVE COMPARATORBiomarkers of tobacco exposure (laboratory values) delivered to health care provider
Usual care (general counseling)
PLACEBO COMPARATORBrochure about pesticides, lead, SHS
Interventions
Providing providers biomarker feedback on childhood secondhand smoke exposure
Eligibility Criteria
You may qualify if:
- M or 24M well-visit
- Scheduled to a lead test
- Current smoker
You may not qualify if:
- Cannot speak English
- No phone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota Department of Medicine
Minneapolis, Minnesota, 55414, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NIH
Study Record Dates
First Submitted
June 16, 2010
First Posted
June 17, 2010
Study Start
June 1, 2010
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
June 17, 2010
Record last verified: 2010-03